Cargando…
On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances
Prostate cancer (PC) is a leading cause of morbidity and mortality among men worldwide. Molecular biomarkers work in conjunction with existing clinicopathologic tools to help physicians decide who to biopsy, re-biopsy, treat, or re-treat. The past decade has witnessed the commercialization of multip...
Autores principales: | Yan, Yiwu, Yeon, Su Yeon, Qian, Chen, You, Sungyong, Yang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703658/ https://www.ncbi.nlm.nih.gov/pubmed/34948334 http://dx.doi.org/10.3390/ijms222413537 |
Ejemplares similares
-
Quantitative proteomic analysis of prostate tissue specimens identifies deregulated protein complexes in primary prostate cancer
por: Zhou, Bo, et al.
Publicado: (2019) -
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
por: Kraaijvanger, Raisa, et al.
Publicado: (2020) -
Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
por: Deacon, Dekker C., et al.
Publicado: (2021) -
Current Status of Biomarkers for Prostate Cancer
por: Velonas, Vicki M., et al.
Publicado: (2013) -
Cardiovascular Biomarkers: Current Status and Future Directions
por: Filipovic, Mark G., et al.
Publicado: (2023)